Charles River Laboratories to purchase Celsis International for US$212m

Published: 13-Jul-2015 Featured companies: Charles River Microbial Solutions
Finance Analysis Microbiology

Expanding the company's endotoxin and microbial detection systems


Charles River Laboratories is set to buy quality control testing firm Celsis International, with US headquarters in Chicago, for US$212m in cash, expanding its endotoxin and microbial detection (EMD) systems. Celsis’s systems are used mainly for product-release testing to help ensure the safe manufacture of drugs and consumer products.

The addition of Celsis' Advance II, Accel, and Innovate systems for non-sterile applications, will complement Charles River's PTS-Micro, a rapid bioburden detection system for sterile biopharmaceutical applications.

Charles River's Chief Executive James Foster said the acquisition will establish the company as a comprehensive provider of rapid quality control testing solutions across multiple industries.

'The transaction nearly doubles the market opportunity for EMD testing products and services, offering access to the consumer products market in addition to our core biopharmaceutical market,' he said.

The transaction is expected to close in this year's third quarter, subject to customary closing conditions.

Featured companies

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in...
See more

You may also like

Analysis

Charles River introduces the first rapid animal-free bacterial endotoxin test

Read more
Charles River has expanded its robust bacterial endotoxin testing (BET) portfolio with a new animal-free testing solution

Trending Articles

  1. Integrity testing of HEPA filters: A practical approach Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit for purpose once installed in your facility
  2. Pharmaceutical containment firm Dec Group opens subsidiary in Japan Dec (Dietrich Engineering Consultants) Group is a global provider of contained powder handling systems that is looking to boost brand identity in Japan
  3. Tips for particle concentration compliance under ISO 14644-1:2015 Apply these six steps to make your cleanroom fit for the new standard, says Hasim Solmaz, Lighthouse Worldwide Solutions
  4. Global industrial group Purever Industries acquires Ardmac Global industrial group, Purever Industries, has acquired the Irish headquartered international specialist contracting firm, Ardmac, for an undisclosed sum
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Environmental Monitoring: Strategies and limitations Environmental monitoring (EM) was one of the topics at Pharmig’s recent two-day meeting in Oxford. Changes in EM guidance, tips on EM strategies and their limitations were all discussed. Susan Birks highlights some of the key points

Relevant companies

See more

Upcoming event

Pharmig Annual Pharmaceutical Microbiology Conference

20–21 November 2024 | Conference | Nottingham, UK See all

You may also like

Analysis

Charles River introduces the first rapid animal-free bacterial endotoxin test

Charles River has expanded its robust bacterial endotoxin testing (BET) portfolio with a new animal-free testing solution
Analysis

Charles River supports Stevenage biocluster's therapies with RightSource facility

RightSource is Charles River’s purpose-built lab offering that provides accessible GMP quality control testing next to the manufacturing floor, launched to support Stevanage's advanced therapies biocluster
Cleaning

Charles River adds animal-free endotoxin testing to Endosafe solution

The global microbial expert has added Endosafe Trillium to its portfolio, a robust recombinant cascade reagent (rCR) assay designed for a sustainable progress
Cleaning

Charles River Laboratories launches next-gen bacterial and fungal sequencing services

The global pharmaceutical and biotechnology service provider has launched Accugenix to improve bacterial identification and fungal ID
Finance

Charles River Laboratories makes $295m acquisition

The acquisition of Explora BioLabs has been made to complement and expand the Charles River Accelerator and Development Lab (CRADL) operation
Microbiology

EN 17141: Understanding the risks of microbiological contamination in pharmaceutical cleanrooms

EN 17141 outlines the importance of understanding the risks of microbial contamination. Being able to accurately identify microbes isolated from the controlled environment is vital to assess risk to pharmaceutical products, and ultimately patients, and ensure that these organisms can be eliminated or controlled
Finance

Charles River secures milestone deals with Takeda and HemaCare

The laboratory giant inks deal with global Japanese drugmaker and completes acquisition of the cell and gene products manufacturer
Subscribe now